These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 36189271)

  • 21. Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer.
    Asghari F; Haghnavaz N; Baradaran B; Hemmatzadeh M; Kazemi T
    Biomed Pharmacother; 2016 Jul; 81():305-317. PubMed ID: 27261608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment.
    Yang N; Zhu S; Lv X; Qiao Y; Liu YJ; Chen J
    Front Immunol; 2018; 9():2491. PubMed ID: 30443251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-oncomir suppression of tumor phenotypes.
    Goga A; Benz C
    Mol Interv; 2007 Aug; 7(4):199-202, 180. PubMed ID: 17827440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs: Key Regulators in Lung Cancer.
    El Founini Y; Chaoui I; Dehbi H; El Mzibri M; Abounader R; Guessous F
    Microrna; 2021; 10(2):109-122. PubMed ID: 34047262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment.
    Liang L; Xu X; Li J; Yang C
    Front Immunol; 2022; 13():883683. PubMed ID: 35634311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.
    Otmani K; Lewalle P
    Front Oncol; 2021; 11():708765. PubMed ID: 34722255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR221/222 in cancer: their role in tumor progression and response to therapy.
    Garofalo M; Quintavalle C; Romano G; Croce CM; Condorelli G
    Curr Mol Med; 2012 Jan; 12(1):27-33. PubMed ID: 22082479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.
    Wilczyński M; Wilczyński J; Nowak M
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
    Shekhar R; Kumari S; Vergish S; Tripathi P
    Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncomirs - microRNAs with a role in cancer.
    Esquela-Kerscher A; Slack FJ
    Nat Rev Cancer; 2006 Apr; 6(4):259-69. PubMed ID: 16557279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells.
    Anfossi S; Fu X; Nagvekar R; Calin GA
    Adv Exp Med Biol; 2018; 1056():87-108. PubMed ID: 29754176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.
    Grzywa TM; Klicka K; Włodarski PK
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33321819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal miRNAs assist in the crosstalk between tumor cells and immune cells and its potential therapeutics.
    Chen X; Li Y; Li M; Xie Y; Wang K; Zhang L; Zou Z; Xiong L
    Life Sci; 2023 Sep; 329():121934. PubMed ID: 37460057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
    Fanale D; Corsini LR; Bono M; Randazzo U; Barraco N; Brando C; Cancelliere D; Contino S; Giurintano A; Magrin L; Pedone E; Perez A; Piraino P; Pivetti A; Giovanni ED; Russo TDB; Prestifilippo O; Gennusa V; Pantuso G; Russo A; Bazan V
    Crit Rev Oncol Hematol; 2024 Jan; 193():104220. PubMed ID: 38036154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Enigma of miRNA Regulation in Cancer.
    Pradhan AK; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2017; 135():25-52. PubMed ID: 28882224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancer.
    Taghvimi S; Vakili O; Soltani Fard E; Khatami SH; Karami N; Taheri-Anganeh M; Salehi M; Negahdari B; Ghasemi H; Movahedpour A
    J Cell Physiol; 2022 Apr; 237(4):2095-2106. PubMed ID: 35128660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in the Tumor Microenvironment.
    Patil N; Allgayer H; Leupold JH
    Adv Exp Med Biol; 2020; 1277():1-31. PubMed ID: 33119862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.
    Pascut D; Pratama MY; Vo NVT; Masadah R; Tiribelli C
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.